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Summary
Objective: To investigate the in vitro and in vivo effects of interleukin (IL)-4 on mechanical stress-induced nitric oxide (NO) expression by
chondrocytes, and destruction of cartilage and NO production in an instability-induced osteoarthritis (OA) model in rat knee joints, respectively.
Materials and methods: Cyclic tensile stress (CTS; 0.5 Hz and 7% elongation) was applied to cultured normal rat chondrocytes with or without
pre-incubation with recombinant rat IL-4 (rrIL-4). Inducible NO synthase (iNOS) mRNA expression and NO production were examined with
real-time polymerase chain reaction and the Griess reaction, respectively. OA was induced in rat knee joints by transection of the anterior
cruciate and medial collateral ligaments and resection of the medial meniscus. rrIL-4 (10, 50, and 100 ng/joint/day) was injected intra-
articularly, and knee joint samples were collected 2, 4, and 6 weeks after surgery. Cartilage destruction was evaluated by the modiﬁed Mankin
score and Osteoarthritis Research Society International scoring system on parafﬁn-embedded sections stained with safranin O. Cleavage of
aggrecan and NO production were examined by immunohistochemistry for aggrecan neoepitope (NITEGE) and of nitrotyrosine (NT),
respectively.
Results: rrIL-4 down-regulated CTS-induced iNOS mRNA expression and NO production by chondrocytes. The intra-articular injection of
rrIL-4 gave rise to a limited, but signiﬁcant amelioration of cartilage destruction, prevention of loss of aggrecan, and decrease in the number
of NT-positive chondrocytes, an effect that was not dose-dependent.
Conclusion: The present study suggests that IL-4 may exert chondroprotective properties against mechanical stress-induced cartilage
destruction, at least in part, by inhibiting NO production by chondrocytes.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common form of arthritis,
and is characterized by destruction of articular cartilage,
osteophyte formation, subchondral bone sclerosis, and
secondary synovitis1,2. Although mechanical stimulation is
essential for the maintenance of chondrocyte metabolism
and homeostasis of articular cartilage3,4, changes in matrix1This research was supported by the Ministry of Education,
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764loading can also induce the production of various pro-
inﬂammatory mediators from chondrocytes5,6 and promote
cartilage matrix degradation. Currently, the loss of aggrecan
from decreased synthesis by chondrocytes and activation
of cartilage matrix degrading enzymes is recognized as
one of the earliest events in the courses of OA, followed
by the mechanical injury of collagen ﬁbrils7.
An inducible form of nitric oxide synthase (iNOS) expres-
sion and nitric oxide (NO) production is increased in OA car-
tilage8,9. An excess amount of NO induces the destruction
of cartilage by activating pro-matrix metalloproteinase
(MMP)10,11, inhibiting the synthesis of aggrecan and type
II collagen by chondrocytes12e14, and promoting chondro-
cyte cell death9. Pro-inﬂammatory cytokines, such as inter-
leukin (IL)-1a, IL-1b, and tumor necrosis factor (TNF)-a, are
potent stimulators of NO production by chondrocytes15e18.
In addition, NO production by chondrocytes is reportedly
inﬂuenced by mechanical stress, including intermittent com-
pression19, cyclic tensile stress (CTS)5, and ﬂuid-induced
765Osteoarthritis and Cartilage Vol. 16, No. 7shear stress12,20. Several investigations have shown that
treatment with NOS inhibitors reduces the progression of
cartilage destruction of experimentally induced OA in ani-
mal models10, suggesting that NO may be an important
therapeutic target for OA.
IL-4 is known as one of the anti-inﬂammatory cytokines
that can potentially protect against severe cartilage destruc-
tion during experimental arthritis21 by suppression of proteo-
lytic enzymes, up-regulation of inhibitors of these enzymes,
and induction of matrix synthesis22. Previous reports have
demonstrated that IL-4 may have the potential to block the
destruction of cartilage by antagonizing inﬂammatory media-
tors, such as IL-123. IL-4 is also known to directly inhibit the
expression of iNOS mRNA and the production of NO24,
and indirectly by inhibiting pro-inﬂammatory cytokines,
such as IL-1b and TNF-a in synoviocytes25,26. Pre-incuba-
tion with IL-4 decreases IL-1a- and TNF-a-induced NO pro-
duction by cultured chondrocytes27; however, whether IL-4
has a protective effect on the destruction of cartilage during
OA is still unknown. It is also unclear whether IL-4 affectsme-
chanical stress-induced gene expression by chondrocytes.
In the present study, we examined the in vitro effect of re-
combinant rat IL-4 (rrIL-4) on mechanical stress-induced
iNOS and NO expression in cultured rat chondrocytes.
We injected rrIL-4 intra-articularly daily into rat knee joints
with instability-induced experimental OA to examine the
in vivo effect of IL-4. The results suggested that IL-4 may
exert chondroprotective properties against excess load on
articular cartilage in OA, at least in part, by inhibiting me-
chanical stress-induced NO production.
Materials and methodsCHONDROCYTE CULTURES AND IL-4 TREATMENTEpiphyseal cartilage obtained from the femoral condyle of 7-day-old Wis-
tar rats was aseptically dissected and the chondrocytes were isolated after
digestion of cartilage fragments in 0.1% a-chymotrypsin (Wako, Osaka,
Japan) and 0.2% collagenase (Sigma, Tokyo, Japan) following the method
described by Bruckner et al.28. Chondrocytes (5 104/ml) were seeded in
six-well plates coated with type I collagen (BioFlex collagen I culture plate;
Flexcell International, McKeesport, PA, USA) and cultured in 3 ml a-mini-
mum essential medium (MEM) containing 10% fetal bovine serum and
100 U/ml penicillin and 100 mg/ml streptomycin. Chondrocytes were incu-
bated in a 5% CO2 humidiﬁed incubator at 37
C for 3 days until cells were
grown to conﬂuence. After washing with phosphate-buffered saline (PBS),
the chondrocytes were incubated with rrIL-4 (0, 1, or 10 ng/ml; Diaclone
Research, Cedex, France) in a 5% CO2 atmosphere for 24 h.EXPOSURE OF CHONDROCYTES TO CTSThe cells seeded on the ﬂexible surface of the BioFlex plates were ex-
posed to the cyclic stress of stretch and relaxation using a Flexercell Strain
Unit (Flexcell International). The vacuum induced a 7% (10 kPa) elongation
in the diameter of the ﬂexible surface. The culture plate bottoms were de-
formed in a cyclic manner (1 s on and 1 s off; 0.5 Hz) and the cells were stim-
ulated for 24 and 48 h. CTS did not change the viability of the cells after 24
and 48 h of stimulation.REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTASE
POLYMERASE CHAIN REACTION (RT-PCR)Real-time PCRwas performed using a LightCycler rapid thermal cycle sys-
tem (Roche Diagnostics, Lewes, UK) according to the manufacturer’s instruc-
tions. Reaction components were prepared to the end-concentration indicated
as follows: 9.4 ml H2O, 1.6 ml MgCl2 (3 mM), 1.0 ml forward primer (0.5 mM),
1.0 ml reverse primer (0.5 mM), 2.0 ml LightCycler Fast Start DNA Master
SYBR Green I (Roche Diagnostics), and 5.0 ml sample. Nucleotides, Taq
DNA polymerase, and buffer were included in the LightCycler-DNA Master
SYBR Green I mix. To improve SYBR Green I quantiﬁcation, a high-
temperature ﬂuorescence measurement was performed. Ampliﬁcation of the
cDNA encoding iNOS was performed with the following speciﬁc oligonucleo-
tide primers: forward primer sequence 50-ACCCAAGGTCTACGTTCAAG-30
and reverse primer sequence 50-AAGACCGCACCGAAGATATC-30.MEASUREMENT OF THE LEVEL OF NO IN THE CULTURED
MEDIACulture supernatants were collected for nitrite measurement. NO forma-
tion was detected by NO3 accumulation in the culture supernatants by an
HPLC-Griess system (ENO-20, Eicom, Kyoto, Japan)29 with sodium nitrite
as a standard. Optical density was measured at 540 nm. Results are ex-
pressed as mM.PREPARATION OF THE EXPERIMENTAL OA MODELEighty Wistar rats, six-week of age, were used for this study. Animals were
anesthetized by intra-peritoneal injection of pentobarbital sodium (50 mg/kg).
The rats’ right knee joints were incised and arthrotomies were performed using
themedial parapatellar approach. First, the anterior cruciate andmedial collat-
eral ligaments (ACL and MCL, respectively) were transected with surgical
scissors. The medial joint space was easily opened with valgus stress. The
medial meniscus was identiﬁed on the posterior corner, removed anteriorly,
and resected with surgical scissors. Using this method, over two-thirds of
the meniscus was resected. The left knee joints were also incised and an
arthrotomy only was performed as a sham operation.INTRA-ARTICULAR INJECTION OF rrIL-4The animals were divided into treatment (n¼ 59) and control (n¼ 21)
groups. The rats in the treatment group received a daily intra-articular injection
of 10 (n¼ 19), 50 (n¼ 20), or 100 (n¼ 20) ng/50 ml of rrIL-4 (Pepro Tech EC
Ltd., London, UK) in the right knee joint and the rats in the control group
(n¼ 21) received an intra-articular injection of 0.01 M PBS as a vehicle in
the same manner. Animals were anesthetized by diethyl ether and the vehicle
or rrIL-4 was injected into the knee joints from just medial side of patella tendon
with the knee joint ﬂexed 90. The medial joint space was easily identiﬁed be-
cause of the severe knee joint instability after surgery. We conﬁrmed that the
tip of the needle reached at the joint space by loss of resistance or aspiration of
joint ﬂuid. The animals were sacriﬁced 2, 4, or 6 weeks after surgery, and the
right knee joint samples were obtained for histologic and immunohistochemi-
cal examination. The left knee joint samples of each of seven rats, 2, 4, and 6
weeks after surgery, were obtained as the sham operation group (n¼ 21).TISSUE PREPARATION AND HISTOLOGIC EVALUATIONHistologic evaluation was performed on full thickness sagittal sections of
cartilage in the weight-bearing area of the medial femoral condyle. The knee
joint samples were dissected, ﬁxed in 4% paraformaldehyde (PFA) for 24 h,
and defatted in alcohol. Then, the knee joint samples were decalciﬁed in
0.3 M ethylenediamine tetraacetate (EDTA; pH 7.5) for 10 days and embed-
ded in parafﬁn. Sections (4.5 mm) were stained with 0.1% safranin O. Histo-
pathologic classiﬁcation of the severity of the OA lesion was graded on
a scale of 0e13, using the modiﬁed Mankin scoring system30,31 and the
OARSI OA cartilage histopathology assessment system32. The modiﬁed
Mankin score is a combined score assessing structure (0e6 points), cellular
abnormalities (0e3 points), and matrix staining (0e4 points). The OARSI
score is a semi-quantitative method to evaluate the histopathology of OA car-
tilage. In the current study, we used the recommended OA score (index of
combined grade and stage, 0e24 points). The histologic evaluation was per-
formed by two independent, blinded observers (MY and KN).IMMUNOHISTOCHEMICAL EVALUATION OF AGGRECAN
NEOEPITOPETo evaluate the cleavage of aggrecan, we performed the immunohisto-
chemical study on the same series of knee joint sections for neoepitope
sequence (NITEGE) generated by aggrecanase-mediated cleavage at
Glu373eAla374 of aggrecan core proteins33. Deparaﬁnized sections were
pre-treated with chondroitinase ABC (1 U/ml; SIGMA, St Louis, MO, USA)
at 37C for 2 h. The endogenous peroxidase was blocked with 3% H2O2 in
PBS at room temperature for 15 min and incubated in normal goat serum
at room temperature for 60 min. Rabbit anti-aggrecan neo antibody (10 mg/
ml; Afﬁnity BioReagents, Golden, CO, USA) was used as the primary anti-
body at 4C overnight. Histoﬁne simple stain rat MAX PO(R) (Nichirei Co.,
Tokyo, Japan) was used as the secondary antibody. The reaction was visu-
alized by diaminobenzidin (DAB; Histoﬁne simple stain DAB, Nichirei Co.,
Tokyo, Japan), resulting in a brown color. Counterstaining was carried out
with hematoxylin. Sections incubated with normal rabbit non-immune serum
or incubated without primary antibody were used as negative controls.IMMUNOHISTOCHEMICAL EVALUATION OF
NITROTYROSINE (NT)Deparaﬁnized sections were pretreated with 0.1 M citrate buffer (pH 6.0)
in an autoclave at 95C for 5 min to retrieve the antigen. The endogenous
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10 min. Rabbit anti-NT antibody (5 mg/ml; Upstate, NY, USA) was used as
the primary antibody at 4C overnight and Histoﬁne simple stain rat MAX
PO(R) (Nichirei Co., Tokyo, Japan) was used as the secondary antibody.
The reaction was visualized by DAB as described above. Counterstaining
was carried out with methyl green. Sections incubated with normal rabbit
non-immune serum or incubated without primary antibody were used as neg-
ative controls.
In the immunostaining section of NT, chondrocyte with deﬁnite, diffusely
stained cytoplasm or nuclei was regarded as positively stained. The popula-
tion of NT-positive chondrocytes was quantiﬁed in the sections of femoral
condyle by counting the number of chondrocytes within full thickness carti-
lage of 6 mm width at 200 magniﬁcations (w100 cells/ﬁeld). The number
of NT-positive chondrocytes was divided by the total number of chondrocytes
to calculate the positive chondrocyte ratio.STATISTICAL ANALYSISAll data are expressed as the mean standard deviation (SD). Differ-
ences among individual sample groups were statistically analyzed by Fish-
er’s protected least signiﬁcant difference (PLSD) post hoc test. A P value
less than 0.05 denoted a statistically signiﬁcant difference.ResultsTHE EFFECTS OF IL-4 ON CTS EXPRESSION OF iNOS mRNA
AND NO PRODUCTIONThe expression of iNOS mRNA by cultured chondrocytes
was signiﬁcantly increased after 24 and 48 h of CTS
(P< 0.001). The mechanical stress-induced iNOS mRNA
expression was suppressed by the pre-treatment of rrIL-4
(1 ng/ml) after 24 and 48 h of CTS. Statistical signiﬁcance
existed only after 48 h of CTS (P< 0.001). rrIL-4 (10 ng/
ml) signiﬁcantly suppressed mechanical stress-induced
iNOS mRNA expression to the baseline level of no mechan-
ical stress after 24 (P< 0.005) and 48 h (P< 0.001) of CTS
(Fig. 1). This suppressive effect of iNOS mRNA by the treat-
ment of rrIL-4 was dose-dependent (P< 0.001).Stress (-), IL-4 (-) Stress (+), IL-4 (1 ng/ml)
Stress (+), IL-4 (10 ng/ml)Stress (+), IL-4 (-)
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Fig. 1. Real-time PCR of iNOS mRNA expression. Chondrocytes
were obtained from the knee joints of 7-day-old Wistar rats and cul-
tured under the load of CTS (0.5 Hz and 7% elongation), or no
stress, for 24 and 48 h, with or without treatment of rrIL-4 (rrIL-4;
1 or 10 ng/ml). Data are shown as the meanSD. Statistical signif-
icance: *P< 0.001 vs no CTS, zP< 0.005, **P< 0.001 vs 24 or
48 h of CTS without rrIL-4 treatment, yP< 0.001 vs 24 h of CTS
with treatment of 1 ng/ml of rrIL-4.NO production from the cultured chondrocytes was not
affected following 24 h of CTS, but was signiﬁcantly in-
creased following 48 h of CTS (P< 0.001). The treatment
of rrIL-4 (10 ng/ml) signiﬁcantly suppressed the increased
production of NO3 (P< 0.005; Table I).HISTOLOGIC EVALUATIONOn the safranin O-stained sections of the femoral con-
dyle, mild progression of cartilage destruction was observed
2 weeks after surgery with surface ﬁbrillation, decreased
number of chondrocytes, and decreased staining of safra-
nin O in the superﬁcial layer. The cartilage lesions were
more severe 4 weeks after surgery, with absence of the su-
perﬁcial layer, surface ﬁbrillation, cluster formation, and de-
creased staining of safranin O in the deeper layer. In some
sections, the full thickness of joint cartilage disappeared
and the subchondral bone was exposed, so-called eburna-
tion. Six weeks after surgery, the cartilaginous lesions were
further developed (Fig. 2).
The sections of femoral condyles from the sham opera-
tion group of rats showed minimum changes in the modiﬁed
Mankin scores and OARSI score through the subsequent
time course following capsulotomy. The modiﬁed Mankin
scores of the control group sections 2, 4, and 6 weeks after
surgery were 2.00 1.73, 4.71 1.49, and 6.00 3.20, re-
spectively, and signiﬁcantly higher 4 and 6 weeks after the
surgery than those of the sham operation group sections
(P< 0.001; Table II). The OARSI score of the control group
sections 2, 4, and 6 weeks after surgery were 5.14 2.85,
9.25 4.89, and 12.29 4.50, respectively, were signiﬁ-
cantly higher than those of the sham operation group sec-
tions at 2 (P< 0.005), 4 (P< 0.001) and 6 weeks
(P< 0.001) after surgery (Table IV). In the control group,
histologic scores gradually increased with time after sur-
gery. There were statistically signiﬁcant differences in the
histologic scores between 2 and 4 weeks, but there were
no signiﬁcant differences between 4 and 6 weeks. OARSI
score is more sensitive to evaluate the early phase of OA
progression than modiﬁed Mankin score, similar results
were obtained using both scoring systems. The histologic
scores of the treatment group sections are shown in Tables
II and IV. The intra-articular injection of rrIL-4 signiﬁcantly
ameliorated cartilage destruction 4 and 6 weeks after sur-
gery; the histologic scores of the treatment group sections
were signiﬁcantly higher than those of the sham operation
group sections. A dose-dependent effect of IL-4 on the inhi-
bition of cartilage destruction did not occur in the present
sets of concentrations of rrIL-4.
The proteoglycan staining in the sections seemed to be
predominant abnormality seen in this rat model of OA.
Among the sub-categories of the modiﬁed Mankin scoringTable I
NO3 concentration in the cultured media of normal rat chondrocytes
after CTS with or without IL-4 pre-incubation
Hours No stress CTS (0.5 Hz and 7% elongation)
IL-4 (e) IL-4 (10 ng/ml)
0 10.490.36
24 10.580.32 11.190.83 10.431.36
48 10.850.56 12.892.61*,y 9.19044**
*P< 0.005 vs no mechanical stress, yP< 0.05 vs 24 h of me-
chanical stress without IL-4 treatment, **P< 0.001 vs 48 h of stress
without IL-4 treatment.
a b c
d e f
g h i
Sham operation group
Control OA group
Treatment group
IL-4 (50 ng/joint/day)
2 weeks 4 weeks 6 weeks 
Fig. 2. Representative histologic appearances of medial femoral condyle cartilage (safranin O staining) of the sham operation group (aec), the
control group (def) and the treatment group (rrIL-4; 50 ng/joint/day; gei) 2 (a, d, and g), 4 (b, e, and h), and 6 (c, f, and i) weeks after surgery.
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group sections, a statistically signiﬁcant loss of safranin O
staining was observed 4 and 6 weeks after surgery. The
matrix staining scores were signiﬁcantly improved by the in-
tra-articular injection of rrIL-4. A dose-dependent effect of
IL-4 on the prevention of proteoglycan loss did not occur
in the present sets of concentrations of rrIL-4. These results
indicate that IL-4 prevented the loss of proteoglycan from
the articular cartilage in this model.IMMUNOHISTOCHEMICAL EVALUATION OF AGGRECAN NEOImmunohistochemical staining for NITEGE neoepitope
demonstrated the distribution and relative amount of G1
fragment of aggrecan core protein in the rat knee joint car-
tilage from the control and treatment groups. In general,
staining intensity appeared to increase with time after sur-
gery and degree of cartilage damage. The cartilage ofTable I
Histological and histochemical evaluation (modified Mankin score) of m
articular injectio
2 Weeks
Modiﬁed Mankin score No. of rats Modiﬁed
Sham 0.28 0.48 7 0.42
OA control 2.00 1.73 7 4.71
IL-4 (10 ng/joint/day) 1.28 1.25 7 2.80
IL-4 (50 ng/joint/day) 0.85 0.69 7 2.66
IL-4 (100 ng/joint/day) 1.66 1.21 6 2.57
*P< 0.001, **P< 0.05, ***P< 0.005 vs sham operation group, yP< 0.
correspond, respectively, yyP< 0.005 vs control OA group at 2 weeks.control group at 2 weeks showed mild staining at superﬁcial
and middle layer, and intense staining throughout the matrix
at 4 weeks. However, the cartilage of control group at 6
weeks showed weak matrix staining and intense cellular
and pericellular matrix staining. In contrast, the cartilage
of treatment group at 2 and 4 weeks showed weak staining
for the neoepitope at superﬁcial, and superﬁcial and middle
layer, respectively, when compared with those of OA con-
trol. The cartilage of treatment group at 6 weeks showed in-
tense matrix staining throughout the matrix (Fig. 3).IMMUNOHISTOCHEMICAL EVALUATION OF NTNO reacts with superoxide radicals to form peroxynitrite.
Addition of peroxynitrite to biological ﬂuid leads to nitration
of aromatic amino acid residues (i.e., NT). Measurement of
NT is useful for demonstrating NO-mediated tissue damage
in vivo. Representative appearances of immunohistochemicalI
edial femoral condyle cartilage with or without treatment of intra-
n of rrIL-4
4 Weeks 6 Weeks
Mankin score No. of rats Modiﬁed Mankin score No. of rats
 0.53 7 0.42 0.53 7
 1.49*,yy 7 6.00 3.20*,yy 7
 0.44** 5 3.42 1.13***,z 7
 1.21**,y 6 2.14 2.26{ 7
 3.91**,y 7 4.00 2.20***,z 7
05, zP< 0.01, {P< 0.001 vs control OA group at the week that
Table III
Loss of proteoglycan evaluated by safranin O staining (matrix staining score)
2 Weeks 4 Weeks 6 Weeks
Modiﬁed Mankin score No. of rats Modiﬁed Mankin score No. of rats Modiﬁed Mankin score No. of rats
Sham 0.00 0.00 7 0.00 0.00 7 0.00 0.00 7
OA control 0.42 0.78 7 2.16 0.83* 7 2.00 1.15* 7
IL-4 (10 ng/joint/day) 0.14 0.37 7 1.40 0.54* 5 1.14 0.90*,y 7
IL-4 (50 ng/joint/day) 0.42 0.53 7 0.83 0.75**,y 6 0.71 0.95**,z 7
IL-4 (100 ng/joint/day) 0.50 0.54 6 0.57 0.78z 7 1.25 0.70* 7
*P< 0.001, **P< 0.05 vs sham operation group, yP< 0.05, zP< 0.001 vs control OA group at the week that correspond, respectively.
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occurred in normal cartilage34,35 and the population of
NT-positive chondrocytes in the sham operation group
sections was 17.1 6.7, 13.4 13.3, and 9.3 9.1%, 2,
4, and 6 weeks after surgery, respectively. No difference
was seen in the population of NT-positive chondrocytes
between each week’s sections. In the control group
sections, the population of NT-positive chondrocytes was
signiﬁcantly higher than in the sham operation group and
was 33.4 8.1 (P< 0.005), 39.9 5.6 (P< 0.001), and
45.2 8.2% (P< 0.001) 2, 4, and 6 weeks after surgery, re-
spectively. The intra-articular injection of rrIL-4 signiﬁcantly
decreased the population of NT-positive chondrocytes at 4
and 6 weeks. In the treatment group (IL-4 50 ng/day), the
population of NT-positive chondrocytes was 32.1 12.8
(n.s.), 28.6 4.8 (P< 0.05), and 28.8 7.6% (P< 0.05),
2, 4, and 6 weeks after surgery, respectively [Fig. 4(B)].
Discussion
The types and magnitude of mechanical stresses are
known to considerably alter chondrocyte metabolism. In-
deed, application of shear stress to OA chondrocytes in-
creases the release of pro-inﬂammatory mediators and
NO and decreases aggrecan and type II collagen expres-
sion, whereas hydrostatic pressure increases matrix macro-
molecule expression3. We have previously reported that
CTS (0.5 Hz and 7% elongation) loaded by a Flexercell
Strain Unit suppresses the expression of aggrecan and
type II collagen mRNA in cultured rat normal chondrocytes,
suggesting that the present set of mechanical stress
seemed to be rather catabolic for chondrocyte metabolism
in vitro36. In the current study, it was demonstrated that
CTS (0.5 Hz and 7% elongation) up-regulated iNOS ex-
pression and increased NO production by rat normal chon-
drocytes. In vivo, chondrocytes in the arthritic joint are
exposed to the high amount of NO in the synovial ﬂuid.
Farrell et al. reported that the nitrite concentration in the sy-
novial ﬂuid from RA patients was 0.91 mM, which wasTable I
Histological and histochemical evaluation (the OARSI OA cartilage histo
with or without treatment of intra-ar
2 Weeks
OARSI score No. of rats OARS
Sham 0.14 0.38 7 0.57
OA control 5.14 2.85** 7 9.25
IL-4 (10 ng/joint/day) 4.00 2.00*** 7 5.14
IL-4 (50 ng/joint/day) 4.57 2.15*** 7 4.50
IL-4 (100 ng/joint/day) 4.43 1.62*** 6 6.57
*P< 0.001, **P< 0.005, ***P< 0.05 vs sham operation group, yP< 0
correspond, respectively, yyP< 0.05, zzP< 0.001 vs control OA group athigher than that in the synovial ﬂuid from OA patients
(0.354 mM)37. In vitro, two of the authors of the current study
reported excessive mechanical stress (CTS 0.5 Hz and 7%
elongation) decreases synthesis of matrix components in
chondrocytes (aggrecan and type II collagen) through
a NO-regulated pathway, probably by increased production
ofw5 mM of NO2/NO3 after the stimulation by CTS
38. Thus,
an increase of 2 mM of NO3 at 48 h after CTS seen in the cur-
rent study appears to bebiologically important. Strikingly, pre-
incubation with rrIL-4 for 24 h down-regulated iNOS mRNA
expression in a dose-dependent manner and treatment with
10 ng/ml of rrIL-4 suppressed NO production to the baseline
level 24 and 48 h after CTS. The molecular mechanism for
IL-4 action againstmechanical stress-inducedNOproduction
is still unclear. It has been demonstrated that high levels of
IL-4 (100 ng/ml) exhibit an inhibitory effect on NO release
enhanced with pro-inﬂammatory cytokines, such as IL-1 or
TNF-a27. Nishisaka et al.24 demonstrated that IL-4 inhibits
an IL-1-evoked increase in intra-cellular Ca2þ ion concentra-
tion in chondrocytes, an important IL-1-induced downstream
signaling. As high magnitude tensile load of 17 kPa at a fre-
quency of 30 cycles/min (0.5 Hz) for 12 h increases the
mRNA levels of IL-1b and TNF-a39, it might be reasonable
to consider that IL-4 inhibited NO production through the
regulation of pro-inﬂammatory cytokine signaling induced by
relatively severe mechanical stress.
In the present study, we also examined the effect of intra-
articular injection of IL-4 on in vivo destruction of cartilage
and NO production using an instability-induced OA model
in rat knee joints. We used the same animal model of OA
which was reported by Hayami et al.40; the transection of
the ACL and the MCL and a partial medial meniscectomy
showed a relatively rapid and severe destruction of carti-
lage. To evaluate the efﬁcacy of IL-4 treatment, it was
critical to determine the amount and interval of IL-4 as
used in the intra-articular injections. van Lent et al.21 dem-
onstrated that the local over-expression of IL-4 prevents
the activation of pro-MMPs during immune complex-
induced arthritis in mice. Cartilage destruction reachesV
pathology assessment system) of medial femoral condyle cartilage
ticular administration of rrIL-4
4 Weeks 6 Weeks
I score No. of rats OARSI score No. of rats
1.13 7 0.14 0.38 7
4.89*,yy 7 12.29 4.50*,zz 7
2.48**,y 5 4.29 2.93***,{ 7
1.97***,z 6 5.71 5.09**,{ 7
5.16**,y 7 5.56 3.36**,{ 7
.05, zP< 0.01, {P< 0.001 vs control OA group at the week that
2 weeks.
Control OA group
Treatment group
IL-4 (50 ng/joint/day)
a b c
d e f
2 weeks 4 weeks 6 weeks
Fig. 3. Representative results of immunohistochemistry for aggrecan neoepitope (NITEGE) in femoral condylar cartilage of knee joints of
OA control (aec) and IL-4 treated (def) animals at 2 weeks (a and d), 4 weeks (b and e), and 6 weeks (c and f) after surgery. Original
magniﬁcation: 200.
769Osteoarthritis and Cartilage Vol. 16, No. 7maximal values around day 4 and is almost completely
blocked by IL-4 at concentrations of 650e750 pg/ml21. Allen
et al.23 demonstrated that the intra-peritoneal injection of
recombinant murine IL-4 (100 ng/rat) prevents the chronic
phase of arthritis induced by streptococcal cell wall frag-
ments by as much as 60e70%. Because of its short half-
life, IL-4 should be administrated continuously23,41. In the
current study, we administered 10, 50, and 100 ng/joint/
day of rrIL-4 into the knee joint of the OA rat model and
the results showed an approximately 33e64% reduction
of cartilage damage by 6 weeks, as evaluated by the mod-
iﬁed Mankin scoring system (Table II). Similar size of reduc-
tion (54e65%) of cartilage damage was also conﬁrmed by
OARSI scoring system. Owing to its short half-life in vivo,
IL-4 treatment has to be given by repeated daily injection
or continuous administration, obviously former is not practi-
cal for treatment in the clinical setting. The fact that no sta-
tistical signiﬁcance existed in the prevention of cartilage
destruction between different doses of rrIL-4 suggested
that the intra-articular injection of rrIL-4 has a limit in amelio-
rating the destruction of cartilage. Recent reports suggest
the possible application of adenoviral vector-mediated
over-expression of IL-421 or dendritic cells genetically engi-
neered to express IL-4 in the treatment of murine collagen-
induced arthritis42 and subsequent cartilage destruction.
Further studies using more chronic and mild OA model sys-
tems would be required to test the therapeutic efﬁcacy of
continuous administration of IL-4 for cartilage destruction.
In the OA model used in the current study, a signiﬁcant
loss of safranin O staining and structural cartilage damage
were noted 4 and 6 weeks after surgery (Table III), probably
due to the decreased synthesis of type II collagen and ag-
grecan by chondrocytes and the subsequent increased pro-
teolytic activity by MMPs and aggrecanases; it is known that
MMP activity in chondrocytes is partly regulated by NO10,11.
NO production was monitored by the number of NT-positive
chondrocytes. The number of NT-positive chondrocytes
was higher in cartilage from the control group rats than in
the sham operation group rats 2 weeks after surgery,
whereas only minimal structural changes were noted in
the cartilage of both groups. Treatment with IL-4 did notaffect the number of NT-positive cells, probably because
the increase of NT protein at 2 weeks may have been corre-
lated with relatively severe post-operative inﬂammation
which could not be sufﬁciently inhibited by the present
amount of rrIL-4. At 4 and 6 weeks, it was demonstrated
that the intra-articular injection of rrIL-4 signiﬁcantly sup-
pressed the increase in the number of NT-positive chondro-
cytes and subsequent loss of aggrecan. These results
suggest that down-regulation of NO production by rrIL-4
may contribute to the prevention in MMP-induced aggrecan
loss in the cartilage of treatment group rats at 4 and 6 weeks.
In addition, IL-4was reported to play a role in the regulation of
a disintegrin and metalloproteinase thrombospondin motif
(ADAMTS)-4 and -9 in chondrocytes43, although the precise
mechanism has not yet been elucidated. Further study is
needed to explore whether the chondroprotective effects of
IL-4 demonstrated in the current study relate to the regulation
of aggrecanases by chondrocytes.
On the other hand, the intra-articular injection of IL-4 did
not completely control NO production from articular carti-
lage and the destruction of cartilage in vivo. These results
suggested that in this OA model, mechanical stress
loaded to the articular cartilage was too strong and IL-4
was not sufﬁcient to neutralize the mechanical stress-in-
duced NO production and cartilage destruction. Another
possible cause of the in vivo limited prevention of cartilage
destruction by the intra-articular injection of rrIL-4 was
a change in the reaction of chondrocytes to IL-4 in OA
cartilage. IL-4 shows different responses on normal and
OA cartilages. In human normal chondrocytes, IL-4 signals
through the type II IL-4 receptor and causes a membrane
hyperpolarization response in a dose-dependent manner.
In chondrocytes from OA cartilage, on the other hand,
IL-4 signals through the type I IL-4 receptor and causes
a membrane depolarization response44. In addition, nor-
mal chondrocytes show an increase in aggrecan mRNA
and a decrease in MMP-3 mRNA following mechanical
stimulation, and these changes are blocked by IL-4 anti-
body. In contrast, chondrocytes isolated from OA cartilage
show no change in aggrecan or MMP-3 mRNA levels fol-
lowing mechanical stimulation45. It was considered that in
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Fig. 4. (A) Representative appearances of immunohistochemistry for NT in medial femoral condylar cartilage of the sham operation group
(aec), the control group (def), and the treatment group (rrIL-4; 50 ng/joint/day; gei) 2 (a, d, and g), 4 (b, e, and h), and 6 (c, f, and i) weeks
after surgery. (B) Population of NT-positive chondrocytes in medial femoral condylar cartilage of the sham operation group, the control group,
and the treatment group (rrIL-4; 50 ng/joint/day). Data are expressed as the meanSD. Statistical signiﬁcance: *P< 0.005, **P< 0.001 vs the
sham operation group and yP< 0.05 vs the control group.
770 M. Yorimitsu et al.: Effect of IL-4 on OA cartilage destructionOA cartilage the phenotype of chondrocytes changes and
the response of the chondrocyte to the anti-inﬂammatory
properties of IL-4 is decreased, and therefore IL-4 only
in part ameliorates the destruction of cartilage in the later
phase of OA.
To summarize, we examined the effect of rrIL-4 on carti-
lage destruction using a relatively severe instability-induced
OA knee in rats. Our results suggested that the intra-
articular injection of rrIL-4 seemed to be effective for the
early phase of cartilage destruction partly by prevention ofproteoglycan loss and promotion of matrix synthesis
through inhibition of NO production. On the other hand,
the present protocol of IL-4 administration may not be sufﬁ-
cient to prevent NO production and proteoglycan loss lead-
ing to the structural damage of cartilage in later stages of
cartilage degeneration in this model of OA.
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